Hillhouse-backed cancer therapy firm Immvira snags $58m

Hillhouse-backed cancer therapy firm Immvira snags $58m

Photo: National Cancer Institute/Unsplash

15 June, 2020

Hillhouse Capital Huagai Capital Immvira

Printed by Unregistered user on Sun, 08 Feb 2026 12:13:46 GMT

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

You may also like

Chinese PE firm Huagai Capital closes third healthcare fund at $434m

China's Huagai Capital leads $146m round in HaiHe Biopharma

Read more from Greater China

Editor’s Take: The Week That Was—Feb 2-7

China’s Capital Today ends evergreen structure, returns to closed-ended funds: Report